• RI - Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
    • português (Brasil)
    • English
    • español
  • Sobre
    • RI Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
  • português (Brasil) 
    • português (Brasil)
    • English
    • español
    • português (Brasil)
    • English
    • español
  • Entrar
Ver item 
  •   Página inicial
  • Escola Paulista de Medicina (EPM)
  • EPM - Artigos
  • Ver item
  •   Página inicial
  • Escola Paulista de Medicina (EPM)
  • EPM - Artigos
  • Ver item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center

Thumbnail
Data
2018
Autor(a)
Nazato, D. M. [UNIFESP]
Abucham Filho, Júlio Zaki [UNIFESP]
Tipo
Revisão
ISSN
1720-8386
É parte de
Journal Of Endocrinological Investigation
DOI
10.1007/s40618-017-0770-3
Metadado
Mostrar registro completo
Resumo
Purpose TSH-secreting pituitary adenomas are among the less prevalent pituitary tumors, corresponding to 0.9-1.5% of all pituitary adenomas in surgical series. Methods A series of 11 patients with TSH-secreting and cosecreting adenomas diagnosed and treated in the last 25 years in a single center is described. Results The mean age at diagnosis was 37 years (range 18-80 years
 
median 23 years)
 
the ratio of male-to-female patients was similar (6M:5F). Only three patients was the correct diagnosis established shortly after the initial medical evaluation. Other four patients were initially diagnosed with other pituitary adenomas (prolactinoma, acromegaly, and non-secreting pituitary tumor) and another four diagnosed with primary hyperthyroidism. There was a mean diagnostic delay of 6.0 years (range 0.5-25 years
 
median 2 years). Nine patients had macroadenomas and two patients had microadenomas. Seven patients underwent pituitary surgery which controlled the disease in only two (one micro- and one noninvasive macroadenoma). The other treatments were directed to the thyroid gland (surgery or I-131 radiotherapy), pituitary radiotherapy, and somatostatin analog. Conclusion In spite of its relatively straightforward diagnosis, which includes clinical/subclinical hyperthyroidism with or without goiter, increased free thyroxine and nonsuppressed TSH levels, and pituitary mass, the diagnosis of TSH-secreting and cosecreting adenomas was frequently unrecognized and thus much delayed. Serum alpha-subunit levels were high in nearly all patients with TSH-secreting adenomas and useful in excluding other conditions in the differential diagnosis. Proper indication and interpretation of simple laboratory tests should be emphasized in medical education to improve diagnostic accuracy.
 
Citação
Journal Of Endocrinological Investigation. New York, v. 41, n. 4, p. 447-454, 2018.
Palavras-chave
TSH-secreting pituitary adenoma
Thyrotropinoma
Pituitary tumors
Hyperthyroidism
Central hyperthyroidism
URI
https://repositorio.unifesp.br/handle/11600/55778
Coleções
  • EPM - Artigos [16058]

DSpace software copyright © 2002-2016  DuraSpace
Entre em contato
Theme by 
Atmire NV
 

 

Navegar

Todo o repositórioComunidades e ColeçõesPor data do documentoAutoresTítulosAssuntosPor data de submissãoEsta coleçãoPor data do documentoAutoresTítulosAssuntosPor data de submissão

Minha conta

Entrar

Estatística

Ver as estatísticas de uso

DSpace software copyright © 2002-2016  DuraSpace
Entre em contato
Theme by 
Atmire NV